Company / Current Assets per Share
ImmunityBio, Inc. Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$0.37
FY2025
5-year range
$0.28 / $0.87
FY2021-FY2025
Trend
+34.2%
vs FY2024
Sector context
#207 of 210
Health Care
What the data says
Among 210 Health Care companies, ImmunityBio, Inc. is in the bottom 1% for current assets per share. Current Assets per Share has fluctuated over the past 10 years, ranging from $0.28 in FY2024 to $2.52 in FY2016.
Based on SEC 10-K filings.
0.37 in FY2025 with a 5-year CAGR of -20.1%.
Declined from $0.70 to $0.37 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +1.5%
- 5-Year CAGR
- -20.1%
- 10-Year CAGR
- -
Sector benchmark
Bottom 1% in Health CareTop 99% of 210This company $0.37 Sector average $134.38
▼
-99.7% below sector average
Key checks
Key Insights
- In FY2025, current assets per share increased 34.2% year-over-year.
- Ranks #207 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2016.
- Lowest current assets per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -7.50 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.37 | +34.2% |
| FY2024 | $0.28 | -60.6% |
| FY2023 | $0.70 | +97.4% |
| FY2022 | $0.35 | -59.6% |
| FY2021 | $0.87 | -22.9% |
| FY2020 | $1.13 | +60.9% |
| FY2019 | $0.71 | -37.2% |
| FY2018 | $1.12 | -30.5% |
| FY2017 | $1.62 | -36.0% |
| FY2016 | $2.52 | -99.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026